Institut for Biomedicin

Tove Christensen

Phase 2 baseline versus treatment clinical trial of the HIV drug raltegravir in patients with active relapsing remitting multiple sclerosis: the INSPIRE study

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisKonferenceabstrakt i tidsskriftForskningpeer review

Standard

Phase 2 baseline versus treatment clinical trial of the HIV drug raltegravir in patients with active relapsing remitting multiple sclerosis: the INSPIRE study. / Marta, M; MacManus, D; Yousry, T; Miller, D; Altmann, DR; Meier, U; Christensen, Tove; Maruszak, H; Holden, D; Bianchi, L; Adiutori, R; Schmierer, K; Turner, B; Giovannoni, G; Gold, J.

I: Multiple Sclerosis Journal, Bind 22 SIII, 2016, s. 188.

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisKonferenceabstrakt i tidsskriftForskningpeer review

Harvard

Marta, M, MacManus, D, Yousry, T, Miller, D, Altmann, DR, Meier, U, Christensen, T, Maruszak, H, Holden, D, Bianchi, L, Adiutori, R, Schmierer, K, Turner, B, Giovannoni, G & Gold, J 2016, 'Phase 2 baseline versus treatment clinical trial of the HIV drug raltegravir in patients with active relapsing remitting multiple sclerosis: the INSPIRE study', Multiple Sclerosis Journal, bind 22 SIII, s. 188.

APA

Marta, M., MacManus, D., Yousry, T., Miller, D., Altmann, DR., Meier, U., Christensen, T., Maruszak, H., Holden, D., Bianchi, L., Adiutori, R., Schmierer, K., Turner, B., Giovannoni, G., & Gold, J. (2016). Phase 2 baseline versus treatment clinical trial of the HIV drug raltegravir in patients with active relapsing remitting multiple sclerosis: the INSPIRE study. Multiple Sclerosis Journal, 22 SIII, 188.

CBE

Marta M, MacManus D, Yousry T, Miller D, Altmann DR, Meier U, Christensen T, Maruszak H, Holden D, Bianchi L, Adiutori R, Schmierer K, Turner B, Giovannoni G, Gold J. 2016. Phase 2 baseline versus treatment clinical trial of the HIV drug raltegravir in patients with active relapsing remitting multiple sclerosis: the INSPIRE study. Multiple Sclerosis Journal. 22 SIII:188.

MLA

Vancouver

Marta M, MacManus D, Yousry T, Miller D, Altmann DR, Meier U o.a. Phase 2 baseline versus treatment clinical trial of the HIV drug raltegravir in patients with active relapsing remitting multiple sclerosis: the INSPIRE study. Multiple Sclerosis Journal. 2016;22 SIII:188.

Author

Marta, M ; MacManus, D ; Yousry, T ; Miller, D ; Altmann, DR ; Meier, U ; Christensen, Tove ; Maruszak, H ; Holden, D ; Bianchi, L ; Adiutori, R ; Schmierer, K ; Turner, B ; Giovannoni, G ; Gold, J. / Phase 2 baseline versus treatment clinical trial of the HIV drug raltegravir in patients with active relapsing remitting multiple sclerosis: the INSPIRE study. I: Multiple Sclerosis Journal. 2016 ; Bind 22 SIII. s. 188.

Bibtex

@article{d7b2f6d2f2b44c53935e60efea864a41,
title = "Phase 2 baseline versus treatment clinical trial of the HIV drug raltegravir in patients with active relapsing remitting multiple sclerosis: the INSPIRE study",
author = "M Marta and D MacManus and T Yousry and D Miller and DR Altmann and U Meier and Tove Christensen and H Maruszak and D Holden and L Bianchi and R Adiutori and K Schmierer and B Turner and G Giovannoni and J Gold",
year = "2016",
language = "English",
volume = "22 SIII",
pages = "188",
journal = "Multiple Sclerosis",
issn = "1352-4585",
publisher = "SAGE Publications Ltd",
note = "null ; Conference date: 14-09-2016 Through 17-09-2016",

}

RIS

TY - ABST

T1 - Phase 2 baseline versus treatment clinical trial of the HIV drug raltegravir in patients with active relapsing remitting multiple sclerosis: the INSPIRE study

AU - Marta, M

AU - MacManus, D

AU - Yousry, T

AU - Miller, D

AU - Altmann, DR

AU - Meier, U

AU - Christensen, Tove

AU - Maruszak, H

AU - Holden, D

AU - Bianchi, L

AU - Adiutori, R

AU - Schmierer, K

AU - Turner, B

AU - Giovannoni, G

AU - Gold, J

PY - 2016

Y1 - 2016

M3 - Conference abstract in journal

VL - 22 SIII

SP - 188

JO - Multiple Sclerosis

JF - Multiple Sclerosis

SN - 1352-4585

Y2 - 14 September 2016 through 17 September 2016

ER -